Save the Date for CBS2026! June 2–5, 2026
0 comments
by
Overview The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
CBS Eastern Canada Research Day - Abstracts due Sept 15th
0 comments
by Patricia Comeau
Dear CBS Members Colleagues, We are excited to share that four of our Eastern Canada student chapters have organized a 2025 Canadian Biomaterials Society Eastern Canada Student Research Day ...
CBS Board of Directors Elections 2025 and CBS2027 Update
0 comments
by Lindsay Fitzpatrick
Dear CBS Member, I have a two important news items to communicate 1. CBS Board Member Elections It is now time to cast your votes for open positions on the CBS Board of Directors...
Neurodegenerative diseases are a leading cause of disability worldwide. Although the individual pathophysiology differs between conditions, they are generally characterized by the progressive loss of structure or function of neurons and supportive glial cells in the brain...
Significant bone loss due to internal or external factors, remains a large orthopedic challenge. Current interventions use either autograft and allograft sources that carry a significant complication burden and show limited functional recovery, emphasizing the demand for an alternative therapeutic solution...
Arterial bypass graft is the primary therapy for patients with advanced vascular occlusion diseases and, in recent years, the development of tissue-engineered vascular grafts has emerged as a promising, clinically applicable alternative to autografts...